Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, Parenti D, Reddy V, Theunissen K, Michallet M, Flowers ME; UVADEX Chronic GVHD Study Group. Greinix HT, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 2011 Dec;17(12):1775-82. doi: 10.1016/j.bbmt.2011.05.004. Epub 2011 May 11. Biol Blood Marrow Transplant. 2011. PMID: 21621629 Free article. Clinical Trial.
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
Przepiorka D, Anderlini P, Saliba R, Cleary K, Mehra R, Khouri I, Huh YO, Giralt S, Braunschweig I, van Besien K, Champlin R. Przepiorka D, et al. Among authors: van besien k. Blood. 2001 Sep 15;98(6):1695-700. doi: 10.1182/blood.v98.6.1695. Blood. 2001. PMID: 11535499 Free article. Clinical Trial.
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Flowers ME, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, Bacigalupo A, Kolb HJ, Bouzas L, Michallet M, Prince HM, Knobler R, Parenti D, Gallo J, Greinix HT. Flowers ME, et al. Among authors: van besien k. Blood. 2008 Oct 1;112(7):2667-74. doi: 10.1182/blood-2008-03-141481. Epub 2008 Jul 11. Blood. 2008. PMID: 18621929 Free article. Clinical Trial.
Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.
Martin PJ, Storer BE, Rowley SD, Flowers ME, Lee SJ, Carpenter PA, Wingard JR, Shaughnessy PJ, DeVetten MP, Jagasia M, Fay JW, van Besien K, Gupta V, Kitko C, Johnston LJ, Maziarz RT, Arora M, Jacobson PA, Weisdorf D. Martin PJ, et al. Among authors: van besien k. Blood. 2009 May 21;113(21):5074-82. doi: 10.1182/blood-2009-02-202937. Epub 2009 Mar 6. Blood. 2009. PMID: 19270260 Free PMC article. Clinical Trial.
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S. Shaughnessy PJ, et al. Among authors: van besien k. Bone Marrow Transplant. 2010 Jun;45(6):1068-76. doi: 10.1038/bmt.2009.307. Epub 2009 Nov 16. Bone Marrow Transplant. 2010. PMID: 19915634 Free PMC article. Clinical Trial.
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease.
Martin PJ, Storer BE, Carpenter PA, Couriel DR, Flowers ME, Gupta V, Hsu JW, Jagasia M, Kitko CL, Maziarz RT, Rowley SD, Shaughnessy PJ, van Besien K, Weisdorf D, Lee SJ. Martin PJ, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 2011 Jan;17(1):124-32. doi: 10.1016/j.bbmt.2010.06.018. Epub 2010 Jun 30. Biol Blood Marrow Transplant. 2011. PMID: 20601033 Free PMC article. Clinical Trial.
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation.
Patel K, Parmar S, Shah S, Shore T, Gergis U, Mayer S, van Besien K. Patel K, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 2016 Mar;22(3):456-61. doi: 10.1016/j.bbmt.2015.10.022. Epub 2015 Oct 31. Biol Blood Marrow Transplant. 2016. PMID: 26524732 Free PMC article.
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
Hsu J, Artz A, Mayer SA, Guarner D, Bishop MR, Reich-Slotky R, Smith SM, Greenberg J, Kline J, Ferrante R, Phillips AA, Gergis U, Liu H, Stock W, Cushing M, Shore TB, van Besien K. Hsu J, et al. Among authors: van besien k. Biol Blood Marrow Transplant. 2018 Feb;24(2):359-365. doi: 10.1016/j.bbmt.2017.10.040. Epub 2017 Nov 8. Biol Blood Marrow Transplant. 2018. PMID: 29128555 Free PMC article.
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
van Besien K, Thall P, Korbling M, Pugh WC, Khouri I, Mehra R, Giralt S, Anderlini P, Amin K, Mirza N, Seong D, Gajewski J, Hester J, Andersson B, Cabanillas F, Champlin R, Przepiorka D. van Besien K, et al. Biol Blood Marrow Transplant. 1997 Aug;3(3):150-6. Biol Blood Marrow Transplant. 1997. PMID: 9310192 Clinical Trial.
337 results